Stay updated on DKRd in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the DKRd in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the DKRd in Newly Diagnosed Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has been updated to include new collaborators, Janssen Scientific Affairs, LLC and Amgen, and a new revision number, v2.15.0. Additionally, the study now references 'Myeloma' and includes the study identifier IRB17-1097.SummaryDifference40%
- Check33 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check91 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to DKRd in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DKRd in Newly Diagnosed Myeloma Clinical Trial page.